Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Lymphoma, Non-Hodgkin 1 Gastroesophageal Adenocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 29 fludarabine 19 Rituximab 15 fludarabine phosphate 12 Specimen Handling 8 obinutuzumab 7 Immunotherapy, Adoptive 7 Lenalidomide 6 Etoposide 6 pirtobrutinib 5 ibrutinib 5 glofitamab 5 axicabtagene ciloleucel 5 Whole-Body Irradiation 5 Mycophenolic Acid 5 venetoclax 4 polatuzumab vedotin 4 Prednisone 4 Melphalan 4 Granulocyte Colony-Stimulating Factor 4 Doxorubicin 4 Blood Component Removal 4 Biopsy 4 pembrolizumab 3 daratumumab 3 X-Rays 3 Vincristine 3 Stem Cell Transplantation 3 Interleukin-2 3 Injections 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, Non-Hodgkin × Single Person × Clear all

NCT06008691 2025-12-29

FIL_MAB

Fondazione Italiana Linfomi - ETS

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡